Abrahams C, Woudberg NJ, Lecour S (2022) Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage? Lipids Health Dis 21:1–16. https://doi.org/10.1186/s12944-022-01694-y

Article  CAS  Google Scholar 

Anker MS, von Haehling S, Coats AJ, Riess H, Eucker J, Porthun J, Butler J, Karakas M, Haverkamp W, Landmesser U, Anker SD (2021) Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study. Eur J Heart Fail 23:145–153. https://doi.org/10.1002/ejhf.2059

Article  CAS  PubMed  Google Scholar 

Bali S, Utaal MS (2019) Serum lipids and lipoproteins: a brief review of the composition, transport and physiological functions. Int J Sci Rep 5:309–314. https://doi.org/10.18203/issn.2454-2156

Article  Google Scholar 

Belger C, Abrahams C, Imamdin A, Lecour S (2024) Doxorubicin-induced cardiotoxicity and risk factors. Int J Cardiol Heart Vasc 50:101332. https://doi.org/10.1016/j.ijcha.2023.101332

Article  PubMed  Google Scholar 

Brulhart-Meynet M-C, Braunersreuther V, Brinck J, Montecucco F, Prost J-C, Thomas A, Galan K, Pelli G, Pedretti S, Vuilleumier N, Mach F, Lecour S, James RW, Frias MA (2015) Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS ONE 10:e0119664. https://doi.org/10.1371/journal.pone.0119664

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camont L, Chapman MJ, Kontush A (2011) Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med 17:594–603. https://doi.org/10.1016/j.molmed.2011.05.013

Article  CAS  PubMed  Google Scholar 

Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF (1997) The 1996 guide for the care and use of laboratory animals. ILAR J 38:41–48. https://doi.org/10.1093/ilar.38.1.41

Article  PubMed  Google Scholar 

Cour M, Pedretti S, Nduhirabandi F, Hacking D, Frias MA, Hausenloy DJ, Lecour S (2024) Interplay between the SAFE and the sphingolipid pathway for cardioprotection. Life Sci 358:123145. https://doi.org/10.1016/j.lfs.2024.123145

Article  CAS  PubMed  Google Scholar 

Cramer L, Hildebrandt B, Kung T, Wichmann K, Springer J, Doehner W, Sandek A, Valentova M, Stojakovic T, Scharnagl H, Riess H, Anker SD, von Haehling S (2014) Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. J Am Coll Cardiol 64:1310–1319. https://doi.org/10.1016/j.jacc.2014.07.948

Article  PubMed  Google Scholar 

Davis T, van Niekerk G, Peres J, Prince S, Loos B, Engelbrecht A-M (2018) Doxorubicin resistance in breast cancer: a novel role for the human protein AHNAK. Biochem Pharmacol 148:174–183. https://doi.org/10.1016/j.bcp.2018.01.012

Article  CAS  PubMed  Google Scholar 

Durham KK, Kluck G, Mak KC, Deng YD, Trigatti BL (2019) Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner. Am J Physiol Heart Circ Physiol 316:H1447–H1457. https://doi.org/10.1152/ajpheart.00432.2018

Article  CAS  PubMed  Google Scholar 

Efentakis P, Varela A, Chavdoula E, Sigala F, Sanoudou D, Tenta R, Gioti K, Kostomitsopoulos N, Papapetropoulos A, Tasouli A, Farmakis D, Davos CH, Klinakis A, Suter T, Cokkinos DV, Iliodromitis EK, Wenzel P, Andreadou I (2020) Levosimendan prevents doxorubicin-induced cardiotoxicity in time-and dose-dependent manner: implications for inotropy. Cardiovasc Res 116:576–591. https://doi.org/10.1093/cvr/cvz163

Article  CAS  PubMed  Google Scholar 

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016) Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer. Lipids Health Dis 15:1–12. https://doi.org/10.1186/s12944-016-0225-4

Article  CAS  Google Scholar 

Frias MA, Lang U, Gerber-Wicht C, James RW (2010) Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res 85:118–126. https://doi.org/10.1093/cvr/cvp289

Article  CAS  PubMed  Google Scholar 

Guo Z, Valenzuela Ripoll C, Picataggi A, Rawnsley DR, Ozcan M, Chirinos JA, Chendamarai E, Girardi A, Riehl T, Evie H, Diab A, Kovacs A, Hyrc K, Ma X, Asnani A, Shewale SV, Scherrer-Crosbie M, Cowart LA, Parks JS, Zhao L, Gordon D, Ramirez-Valle F, Margulies KB, Cappola TP, Desai AA, Pedersen LN, Bergom C, Stitziel NO, Rettig MP, DiPersio JF, Hajny S, Christoffersen C, Diwan A, Javaheri A (2023) Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury. J Am Coll Cardiol Basic Trans Science 8:340–355. https://doi.org/10.1016/j.jacbts.2022.09.010

Article  Google Scholar 

Hernáez Á, Castañer O, Elosua R, Pintó X, Estruch R, Salas-Salvadó J, Corella D, Arós F, Serra-Majem L, Fiol M, Ortega-Calvo M, Ros E, Martínez-González MÁ, de la Torre R, López-Sabater C, Fitó M (2017) Mediterranean diet improves high-density lipoprotein function in high-cardiovascular-risk individuals: a randomized controlled trial. Circulation 135:633–643. https://doi.org/10.1161/circulationaha.116.023712

Article  PubMed  Google Scholar 

Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S (2005) Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Clin Chim Acta 360:37–45. https://doi.org/10.1016/j.cccn.2005.04.004

Article  CAS  PubMed  Google Scholar 

Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ (2021) IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-Cardioprotection cost action. Basic Res Cardiol 116:52. https://doi.org/10.1007/s00395-021-00893-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

López-Olmos V, Carreón-Torres E, Luna-Luna M, Flores-Castillo C, Martínez-Ramírez M, Bautista-Pérez R, Franco M, Sandoval-Zárate J, Roldán F-J, Aranda-Fraustro A, Soria-Castro E, Muñoz-Vega M, Fragoso J-M, Vargas-Alarcón G, Péréz-Méndez O (2016) Increased hdl size and enhanced apo ai catabolic rates are associated with doxorubicin-induced proteinuria in New Zealand white rabbits. Lipids 51:311–320. https://doi.org/10.1007/s11745-016-4120-6

Article  CAS  PubMed  Google Scholar 

López-Sendón J, Álvarez-Ortega C, Zamora Auñon P, Buño Soto A, Lyon AR, Farmakis D, Cardinale D, Canales Albendea M, Feliu Batlle J, Rodríguez Rodríguez I, Albaladejo A, Mediavilla G, González-Juanatey JR, Martínez Monzonis AM, Prieto Gómez P, González-Costello J, Antolín JMS, Cadenas Chamorro R, López-Fernández T (2020) Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. Eur Heart J 41:1720–1729. https://doi.org/10.1093/eurheartj/ehaa006

Article  PubMed  Google Scholar 

Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, Kazuaki T (2012) Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res 72:726–735. https://doi.org/10.1158/0008-5472.can-11-2167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagahashi M, Tsuchida J, Moro K, Hasegawa M, Tatsuda K, Woelfel IA, Takabe K, Wakai T (2016) High levels of sphingolipids in human breast cancer. J Surg Res 204:435–444. https://doi.org/10.1016/j.jss.2016.05.022

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qu J, Zhao X, Wang J, Liu C, Sun Y, Cai H, Liu J (2018) Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer. Oncol Lett 15:5236–5242. https://doi.org/10.3892/ol.2018.7915

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rached FH, Chapman MJ, Kontush A (2015) Hdl particle subpopulations: focus on biological function. BioFactors 41:67–77. https://doi.org/10.1002/biof.1202

Article  CAS  PubMed  Google Scholar 

Sangweni NF, Moremane M, Riedel S, van Vuuren D, Huisamen B, Mabasa L, Barry R, Johnson R (2020) The prophylactic effect of pinocembrin against doxorubicin-induced cardiotoxicity in an in vitro H9c2 cell model. Front Pharmacol 11:1172. https://doi.org/10.3389/fphar.2020.01172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sattler K, Gräler M, Keul P, Weske S, Reimann C-M, Jindrová H, Kleinbongard P, Sabbadini R, Bröcker-Preuss M, Erbel R, Heusch G, Levkau B (2015) Defects of high-density lipoproteins in coronary artery disease caused by low sphingosine-1-phosphate content: correction by sphingosine-1-phosphate—loading. J Am Coll Cardiol 66:1470–1485. https://doi.org/10.1016/j.jacc.2015.07.057

Article  CAS  PubMed